These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3356480)

  • 1. Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China.
    Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
    Int J Androl; 1988 Feb; 11(1):1-11. PubMed ID: 3356480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of men in the recovery period immediately after the cessation of gossypol treatment.
    Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
    Contraception; 1988 Feb; 37(2):119-28. PubMed ID: 3131064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol.
    Gu ZP; Wang YX; Sang GW; Wang WC; Chen ZX; Zhao XJ; Shao QX; Jiang Y
    Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
    Coutinho EM; Athayde C; Atta G; Gu ZP; Chen ZW; Sang GW; Emuveyan E; Adekunle AO; Mati J; Otubu J; Reidenberg MM; Segal SJ
    Contraception; 2000 Jan; 61(1):61-7. PubMed ID: 10745071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antispermatogenic action of gossypol in men.
    Coutinho EM; Melo JF; Barbosa I; Segal SJ
    Fertil Steril; 1984 Sep; 42(3):424-30. PubMed ID: 6468676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for the "male pill".
    Herndon N
    Netw Res Triangle Park N C; 1992 Aug; 13(1):20-3. PubMed ID: 12317724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gossypol as oral contraceptive for male: trial case report.
    Hoshiai H; Uehara S; Mori R; Nagaike F; Tsuiki A; Suzuki M
    Tohoku J Exp Med; 1982 Nov; 138(3):275-80. PubMed ID: 6818716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with gossypol in non-Chinese men: a follow-up.
    Coutinho EM; Melo JF
    Contraception; 1988 Feb; 37(2):137-51. PubMed ID: 3286112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone.
    Anderson RA; Wallace EM; Groome NP; Bellis AJ; Wu FC
    Hum Reprod; 1997 Apr; 12(4):746-51. PubMed ID: 9159436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.